Skip to content

An open label study of the elevation of plasma catechin concentration

An open label study of the elevation of plasma catechin concentration - An open label study of the elevation of plasma catechin concentration

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000040022
Enrollment
80
Registered
2020-04-03
Start date
2020-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese adults

Interventions

Single oral dose of green tea catechins in a fasting state

Sponsors

Central Research Institute, ITO EN, Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects are competent to consent, keep the rules of the study 2. Subjects who are judged by the physician as eligible to participate in the trial

Exclusion criteria

Exclusion criteria: . Subjects undergoing medical treatment or having a medical history of malignant tumor, heart failure, or myocardial infarction 2. Subjects carrying a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, sleep apnea syndrome, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage as part of their daily intake 5. Subjects regularly taking medications (including herbal medicines) and supplements 6. Subjects allergic to medications and/or the test-food-related products 7. Subjects who are pregnant, lactating, or intending to become pregnan 8. Subjects who participated in other clinical tests in 3 months before a consent form acquisition day or who are planning to participate in the test duration 9. Subjects who are judged by the physician as ineligible to participate in the trial

Design outcomes

Primary

MeasureTime frame
Plasma catechin concentration

Secondary

MeasureTime frame
SNPs associated with plasma catechin concentration

Countries

Japan

Contacts

Public ContactMakoto Kobayashi

ITO EN, Ltd Central Research Institute

m-kobayasi@itoen.co.jp0548-54-1247

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026